Skip to Main content Skip to Navigation
Journal articles

Hypoxia-driven intratumor heterogeneity and immune evasion

Abstract : While it is widely accepted that high intratumoral heterogeneity confers serious challenges in the emerging resistance and the subsequent effective therapeutic targeting of cancer, the underlying biology of intratumoral heterogeneity remains elusive. In particular, it remains to be fully elucidated how microenvironmental factors shape genetic and non-genetic heterogeneity, which in turn determine the course of tumor evolution and clinical progression. In this context, hypoxia, a hallmark of most growing cancers, characterized by decreased O2 partial pressure is a key player of the tumor microenvironment. Despite extensive data indicating that hypoxia promotes cellular metabolic adaptation, immune suppression and various steps of tumor progression via hypoxia regulated gene transcription, much less is known about the role of hypoxia in mediating therapy resistance as a driver of tumor evolution through genetic and non-genetic mechanisms. In this review, we will discuss recent evidence supporting a prominent role of hypoxia as a driver of tumor heterogeneity and highlight the multifaceted manner by which this in turn could impact cancer evolution, reprogramming and immune escape. Finally, we will discuss how detailed knowledge of the hypoxic footprint may open up new therapeutic avenues for the management of cancer.
Document type :
Journal articles
Complete list of metadata
Contributor : Roselyne Tâche <>
Submitted on : Thursday, June 17, 2021 - 3:33:17 PM
Last modification on : Saturday, July 31, 2021 - 3:57:03 AM


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Links full text



Stéphane Terry, Agnete S.T. Engelsen, Stéphanie Buart, Walid Shaaban Elsayed, Goutham Hassan Venkatesh, et al.. Hypoxia-driven intratumor heterogeneity and immune evasion. Cancer Letters, Elsevier, 2020, 492, pp.1-10. ⟨10.1016/j.canlet.2020.07.004⟩. ⟨hal-03263783⟩



Record views